{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:54:36Z","timestamp":1781769276932,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DC003915"],"award-info":[{"award-number":["R01DC003915"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jgar.2026.03.013","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:13:59Z","timestamp":1775060039000},"page":"18-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A humanized monoclonal antibody potentiates killing of Pseudomonas aeruginosa by common antibiotics"],"prefix":"10.1016","volume":"49","author":[{"given":"Jaime D.","family":"Rhodes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren O.","family":"Bakaletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2026.03.013_bib0001","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1569-1993(02)00104-2","article-title":"Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies","volume":"1","author":"Hoiby","year":"2002","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jgar.2026.03.013_bib0002","unstructured":"Interagency Coordination Group on Antimicrobial Resistance. No time to wait: Securing the future from drug-resistant infections. World Health Organization; 2019."},{"key":"10.1016\/j.jgar.2026.03.013_bib0003","unstructured":"Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2019. U.S. Department of Health and Human Services; 2019."},{"key":"10.1016\/j.jgar.2026.03.013_bib0004","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.295.5559.1487","article-title":"Extracellular DNA required for bacterial biofilm formation","volume":"295","author":"Whitchurch","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jgar.2026.03.013_bib0005","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/mi.2011.27","article-title":"Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteins","volume":"4","author":"Goodman","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jgar.2026.03.013_bib0006","doi-asserted-by":"crossref","first-page":"25068","DOI":"10.1073\/pnas.1909017116","article-title":"The extracellular DNA lattice of bacterial biofilms is structurally related to Holliday junction recombination intermediates","volume":"116","author":"Devaraj","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jgar.2026.03.013_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.10.010","article-title":"Z-form extracellular DNA is a structural component of the bacterial biofilm matrix","volume":"184","author":"Buzzo","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jgar.2026.03.013_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40284-5","article-title":"Nontypeable Haemophilus influenzae released from biofilm residence by monoclonal antibody directed against a biofilm matrix component display a vulnerable phenotype","volume":"13","author":"Wilbanks","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2026.03.013_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01877-21","article-title":"A humanized monoclonal antibody potentiates killing of diverse biofilm-forming respiratory tract pathogens by antibiotics","volume":"66","author":"Kurbatfinski","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.03.013_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102867","article-title":"Targeting a bacterial DNABII protein with a chimeric peptide immunogen or humanised monoclonal antibody to prevent or treat recalcitrant biofilm-mediated infections","volume":"59","author":"Novotny","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jgar.2026.03.013_bib0011","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0. EUCAST; 2020."},{"key":"10.1016\/j.jgar.2026.03.013_bib0012","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/idr17040080","article-title":"Effects of CFTR modulators on Pseudomonas aeruginosa infections in cystic fibrosis","volume":"17","author":"Pescaru","year":"2025","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.jgar.2026.03.013_bib0013","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12890-016-0339-5","article-title":"Cystic fibrosis lung environment and Pseudomonas aeruginosa infection","volume":"16","author":"Bhagirath","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jgar.2026.03.013_bib0014","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41541-019-0137-1","article-title":"Redirecting the immune response towards immunoprotective domains of a DNABII protein resolves experimental otitis media","volume":"4","author":"Novotny","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jgar.2026.03.013_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1202215","article-title":"ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics","volume":"14","author":"Kurbatfinski","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2026.03.013_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2023.100166","article-title":"Disruption of nontuberculous mycobacteria biofilms induces a highly vulnerable to antibiotic killing phenotype","volume":"6","author":"Kurbatfinski","year":"2023","journal-title":"Biofilm"},{"key":"10.1016\/j.jgar.2026.03.013_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03066-24","article-title":"Respiratory tract antimicrobial peptides more effectively killed multiple methicillin-resistant Staphylococcus aureus and nontypeable Haemophilus influenzae isolates after disruption from biofilm residence","volume":"13","author":"Kurbatfinski","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2026.03.013_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2020.100039","article-title":"Nontypeable Haemophilus influenzae newly released (NRel) from biofilms by antibody-mediated dispersal versus antibody-mediated disruption are phenotypically distinct","volume":"2","author":"Mokrzan","year":"2020","journal-title":"Biofilm"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:30:53Z","timestamp":1781767853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716526000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":18,"alternative-id":["S2213716526000470"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2026.03.013","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A humanized monoclonal antibody potentiates killing of Pseudomonas aeruginosa by common antibiotics","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2026.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}